Total Payments
$4,596
2024 Payments
$378.45
Companies
31
Transactions
278
Medicare Patients
11,762
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$4,392 (95.6%)
Education$204.10 (4.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,392 | 275 | 95.6% |
| Education | $204.10 | 3 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $683.98 | 64 | $0 (2023) |
| Amgen Inc. | $537.83 | 38 | $0 (2023) |
| PFIZER INC. | $471.63 | 28 | $0 (2024) |
| Boston Scientific Corporation | $444.27 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $346.10 | 29 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $261.58 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $198.00 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $183.24 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $173.02 | 11 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $171.14 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $378.45 | 18 | ABIOMED ($86.56) |
| 2023 | $785.83 | 33 | Boston Scientific Corporation ($229.37) |
| 2022 | $424.58 | 20 | Boston Scientific Corporation ($150.00) |
| 2021 | $463.26 | 32 | Amgen Inc. ($69.98) |
| 2020 | $448.60 | 26 | PFIZER INC. ($179.69) |
| 2019 | $497.30 | 40 | Novartis Pharmaceuticals Corporation ($167.75) |
| 2018 | $929.38 | 63 | Astellas Pharma US Inc ($198.00) |
| 2017 | $668.93 | 46 | Novartis Pharmaceuticals Corporation ($140.90) |
All Payment Transactions
278 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.15 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.45 | General |
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/19/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology | ||||||
| 07/11/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/09/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/29/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Transcatheter Heart Valves | ||||||
| 03/28/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/23/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/30/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 01/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $44.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $41.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/05/2024 | Bard Peripheral Vascular, Inc. | Venclose Maven Catheter (Device) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: Vascular/Oncology | ||||||
| 12/20/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/12/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: DIABETES | ||||||
| 11/22/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/14/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/07/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.24 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,166 | 5,240 | $2.1M | $368,271 |
| 2022 | 28 | 2,982 | 4,398 | $1.2M | $281,249 |
| 2021 | 22 | 2,976 | 4,538 | $1.1M | $290,028 |
| 2020 | 22 | 2,638 | 3,950 | $905,273 | $223,460 |
Total Patients
11,762
Total Services
18,126
Medicare Billing
$1.2M
Procedure Codes
112
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 672 | 1,453 | $819,216 | $143,836 | 17.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 196 | 196 | $401,496 | $77,338 | 19.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 168 | 430 | $144,716 | $28,338 | 19.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 125 | 500 | $171,528 | $20,914 | 12.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 121 | 121 | $109,119 | $19,375 | 17.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 86 | 88 | $72,798 | $12,680 | 17.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 163 | 166 | $107,520 | $12,216 | 11.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 638 | 1,020 | $68,402 | $11,746 | 17.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 215 | 215 | $68,716 | $11,678 | 17.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 112 | $44,772 | $7,257 | 16.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $23,184 | $4,505 | 19.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 81 | 81 | $23,728 | $4,466 | 18.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 390 | 516 | $18,592 | $3,293 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $16,130 | $2,675 | 16.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 17 | $9,678 | $1,729 | 17.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $8,660 | $1,596 | 18.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 31 | $6,025 | $1,313 | 21.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 13 | 14 | $6,338 | $1,230 | 19.4% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 33 | 33 | $3,338 | $657.03 | 19.7% |
| 85610 | Blood test, clotting time | Office | 2023 | 15 | 119 | $2,142 | $499.80 | 23.3% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 33 | 33 | $1,900 | $369.75 | 19.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 19 | 19 | $1,732 | $333.75 | 19.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 19 | 19 | $1,143 | $224.77 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 650 | 1,275 | $506,207 | $131,349 | 25.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 146 | 384 | $97,223 | $23,484 | 24.2% |
About Dr. Steven Georgeson, MD
Dr. Steven Georgeson, MD is a Internal Medicine healthcare provider based in Bridgewater, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487627741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Georgeson, MD has received a total of $4,596 in payments from pharmaceutical and medical device companies, with $378.45 received in 2024. These payments were reported across 278 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,392).
As a Medicare-enrolled provider, Georgeson has provided services to 11,762 Medicare beneficiaries, totaling 18,126 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nuclear Cardiology, Cardiovascular Disease
- Location Bridgewater, NJ
- Active Since 02/08/2006
- Last Updated 04/26/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1487627741
Products in Payments
- ENTRESTO (Drug) $671.13
- ELIQUIS (Drug) $466.88
- WATCHMAN Access System (Device) $318.00
- Repatha (Biological) $283.30
- VYNDAQEL (Drug) $279.97
- XARELTO (Drug) $261.58
- Corlanor (Drug) $254.53
- JARDIANCE (Drug) $183.24
- LifeVest (Device) $171.14
- PRALUENT (Drug) $152.83
- Vascepa (Drug) $133.33
- Impella (Device) $121.46
- NEXLETOL (Drug) $95.78
- VERQUVO (Drug) $90.59
- PRALUENT ALIROCUMAB INJECTION (Biological) $74.52
- BYSTOLIC (Drug) $73.43
- Livalo (Drug) $66.07
- WATCHMAN FLX (Device) $65.08
- FARXIGA (Drug) $44.37
- INJECTAFER (Drug) $44.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bridgewater
Dr. Sanjukta Sanyal, M.d, M.D
Internal Medicine — Payments: $36,192
Internal Medicine $36,192
Dr. Sharan Mahal, Md, MD
Internal Medicine — Payments: $14,948
Internal Medicine $14,948
Daniel Fung, M.d, M.D
Internal Medicine — Payments: $9,907
Internal Medicine $9,907
Dr. Alexander Kudryk, M.d, M.D
Internal Medicine — Payments: $8,689
Internal Medicine $8,689
Dr. Yimei You, M.d, M.D
Internal Medicine — Payments: $8,185
Internal Medicine $8,185
Dr. Jason Hall, Md, MD
Internal Medicine — Payments: $4,124
Internal Medicine $4,124